Stock Events

Stock Events

Glaukos 

€117.46
0
+€12.8+12.23% Monday 06:03

Statistics

Day High
117.46
Day Low
117.46
52W High
117.46
52W Low
65.5
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5AugExpected
Q4 2025
Q1 2026
Next
-0.24
-0.21
-0.18
-0.15
Expected EPS
-0.18174305474
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6GJ.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Align Technology
ALGN
Mkt Cap12.81B
Align Technology competes in the broader medical devices sector, focusing on dental products but shares market space in medical technology advancements.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its medical devices segment, competes in various areas including surgical technologies which can overlap with Glaukos' market.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, while primarily known for pharmaceuticals, has interests in eye care through its acquisition of Allergan, making it a competitor in the ophthalmology space.
Novartis
NVS
Mkt Cap279.67B
Novartis competes directly in the eye care market through its Alcon division, offering products and solutions in eye health that rival Glaukos' offerings.
Staar Surgical
STAA
Mkt Cap1.35B
STAAR Surgical specializes in ophthalmic products, directly competing with Glaukos in the market for surgical eye care solutions.
Bausch Health Companies
BHC
Mkt Cap2.11B
Bausch Health Companies, through its eye health division, competes in the same ophthalmology and eye care markets as Glaukos.
Cooper Companies
COO
Mkt Cap12.17B
The Cooper Companies operate in the medical device sector focusing on contact lens and women's health, but its eye care division competes with Glaukos in providing medical devices for eye conditions.
Integra Lifesciences
IART
Mkt Cap830.03M
Integra LifeSciences, a provider of medical devices for surgery, competes indirectly with Glaukos through its offerings in surgical instruments and regenerative technologies.

About

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.
Show more...
CEO
Mr. Thomas William Burns
Employees
995
Country
United States
ISIN
US3773221029

Listings

STU
DE
6GJ.STU
MU
DE
6GJ.MU
XNYS
US
GKOS
BOATS
BOATS
GKOS.BOATS

0 Comments

Share your thoughts

FAQ

What is Glaukos stock price today?▼
The current price of 6GJ.MU is €117.46 EUR — it has increased by +12.23% in the past 24 hours. Watch Glaukos stock price performance more closely on the chart.
What is Glaukos stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Glaukos stocks are traded under the ticker 6GJ.MU.
Is Glaukos stock price growing?▼
6GJ.MU stock has risen by +12.96% compared to the previous week, the month change is a +23.01% rise, over the last year Glaukos has showed a +53.54% increase.
When is the next Glaukos earnings date?▼
Glaukos is going to release the next earnings report on August 05, 2026.
What were Glaukos earnings last quarter?▼
6GJ.MU earnings for the last quarter are -0.15 EUR per share, whereas the estimation was -0.24 EUR resulting in a +35.87% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Glaukos have?▼
As of May 06, 2026, the company has 995 employees.
In which sector is Glaukos located?▼
Glaukos operates in the Health & Wellness sector.
When did Glaukos complete a stock split?▼
Glaukos has not had any recent stock splits.
Where is Glaukos headquartered?▼
Glaukos is headquartered in Aliso Viejo, United States.